ZNF443 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.072600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.607200E-01
Normal-vs-Stage2
1.814360E-01
Normal-vs-Stage3
1.486650E-01
Normal-vs-Stage4
8.902800E-01
Stage1-vs-Stage2
5.718200E-02
Stage1-vs-Stage3
7.216100E-02
Stage1-vs-Stage4
3.657000E-01
Stage2-vs-Stage3
2.128600E-01
Stage2-vs-Stage4
6.955400E-01
Stage3-vs-Stage4
9.868000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.591600E-01
Normal-vs-AfricanAmerican
5.868200E-01
Normal-vs-Asian
3.948000E-01
Caucasian-vs-AfricanAmerican
7.367000E-01
Caucasian-vs-Asian
7.289400E-01
AfricanAmerican-vs-Asian
9.472200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.101400E-01
Normal-vs-Female
1.433030E-01
Male-vs-Female
5.433400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.656100E-02
Normal-vs-Age(41-60Yrs)
7.635800E-01
Normal-vs-Age(61-80Yrs)
1.012760E-01
Normal-vs-Age(81-100Yrs)
5.656000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.342000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
2.048000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.440600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.808800E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.045400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.838600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.541000E-01
Normal-vs-Daily Drinker
1.359540E-02
Normal-vs-Weekly Drinker
1.669420E-01
Normal-vs-Occasional Drinker
5.734200E-01
Normal-vs-Social Drinker
6.255200E-01
Non Drinker-vs-Daily Drinker
1.506220E-01
Non Drinker-vs-Weekly Drinker
5.572200E-01
Non Drinker-vs-Occasional Drinker
7.995400E-01
Non Drinker-vs-Social Drinker
2.439000E-01
Daily Drinker-vs-Weekly Drinker
5.346000E-01
Daily Drinker-vs-Occasional Drinker
1.551950E-01
Daily Drinker-vs-Social Drinker
2.984300E-02
Weekly Drinker-vs-Occasional Drinker
4.847800E-01
Weekly Drinker-vs-Social Drinker
1.500220E-01
Occasional Drinker-vs-Social Drinker
4.345000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.668230E-02
Normal-vs-Grade 2
6.178400E-03
Normal-vs-Grade 3
1.630420E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.761800E-01
Grade 1-vs-Grade 3
6.884000E-01
Grade 1-vs-Grade 4
1.668230E-02
Grade 2-vs-Grade 3
8.001200E-01
Grade 2-vs-Grade 4
6.178400E-03
Grade 3-vs-Grade 4
1.630420E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.343800E-01
Normal-vs-NonDiabetic
2.938200E-01
Diabetic-vs-NonDiabetic
5.206400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.514600E-01
Normal-vs-NoPancreatitis
6.637500E-02
Pancreatitis-vs-NoPancreatitis
7.130800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.437800E-01
Normal-vs-N1
2.653200E-01
N0-vs-N1
9.581600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.638400E-01
Normal-vs-TP53-NonMutant
7.787400E-01
TP53-Mutant-vs-TP53-NonMutant
3.989400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
